Clinical Trials Logo

Protein-Losing Enteropathies clinical trials

View clinical trials related to Protein-Losing Enteropathies.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT06003881 Available - Clinical trials for CD55-Deficient Protein-Losing Enteropathy

Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy

CHAPLE Disease
Start date: n/a
Phase:
Study type: Expanded Access

The program is to provide access to an experimental drug called pozelimab and to document the long-term safety of pozelimab in patients with Protein-Losing Enteropathy (PLE). CD55-deficient PLE/CHAPLE disease is a rare inherited disease of the immune system. This can be a life-threatening condition that is usually found when patients are children.